Cambridge Sleep Sciences’ device is trialled in Parkinson’s

Sleep disturbances are a common feature for people with Parkinson’s disease, and a device developed to help people with insomnia is now being trialled to see if it can improve their sleep q

Chasing Merck, Eisai launches insomnia drug Dayvigo in Japan

Eisai has launched its insomnia drug Dayvigo in Japan, the second in a new class of medicines after Merck & Co’s Belsomra, which made its debut there in 2014.

Idorsia on course to take on Eisai and Merck & Co after late...

Switzerland’s Idorsia says it is on course to file a potential next-generation insomnia drug around the end of this year after a second batch of supportive phase 3 trial results, although t

FDA clears Eisai’s insomnia drug Dayvigo

Ergomed hails insomnia and cancer deals

UK biotech has stake in two potentially lucrative drugs thanks to hybrid business model